Parkview Health System, founded in 1878 as Fort Wayne City Hospital is a network of 10 community hospitals and more than 100 clinic locations in northeast Indiana and northwest Ohio. The not-for-profit Parkview Health System is the region's largest employer with more than 13,000.

During the past decade, Parkview Hospital Randallia conducted 42 clinical trials. In the 10-year time frame, 42 clinical trials started and 33 clinical trials were completed, i.e. on average, 78.6% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 24 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Parkview Hospital Randallia" #1 sponsor was "National Cancer Institute (NCI)" with 26 trials, followed by "NRG Oncology" with 14 trials sponsored, "Alliance for Clinical Trials in Oncology" with 11 trials sponsored, "Radiation Therapy Oncology Group" with 6 trials sponsored and "SWOG Cancer Research Network" with 6 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Parkview Hospital Randallia" #1 collaborator was "National Cancer Institute (NCI)" with 45 trials as a collaborator, "NRG Oncology" with 21 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Radiation Therapy Oncology Group" with 7 trials as a collaborator and "Agenus Inc." with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Parkview Hospital Randallia" are "Recurrent Non-Small Cell Lung Carcinoma" (5 trials), "Stage II Breast Cancer" (5 trials), "Prostate Cancer" (4 trials), "Stage IVA Uterine Corpus Cancer AJCC v7" (4 trials) and "Endometrial Serous Adenocarcinoma" (3 trials). Many other conditions were trialed in "Parkview Hospital Randallia" in a lesser frequency.

Most popular intervention types in "Parkview Hospital Randallia" are "Drug" (55 trials), "Radiation" (40 trials), "Other" (39 trials), "Biological" (20 trials) and "Procedure" (17 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (25 trials), "Quality-of-Life Assessment" (15 trials), "Intensity-Modulated Radiation Therapy" (14 trials), "Cisplatin" (10 trials) and "Paclitaxel" (9 trials). Other intervention names were less common.

The vast majority of trials in "Parkview Hospital Randallia" are 48 trials for "All" genders, 17 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Parkview Hospital Randallia". undefined are not yet recruiting, 7 are recruiting, 42 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Parkview Hospital Randallia, 2 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Parkview Hospital Randallia, 3 "Phase 1" clinical trials were conducted, 35 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".